Deutsch
A A A
DE
Bereichsnavigation

Previous
Disclosure of voting rights | 03/05/2020

RHÖN-KLINIKUM AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

RHÖN-KLINIKUM Aktiengesellschaft05.03.2020 / 17:45 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings1. Details of issuer
Name: RHÖN-KLINIKUM Aktiengesellschaft
Street: Salzburger Leite 1
Postal code: 97616
City: Bad Neustadt a.d.SaaleGermany
Legal Entity Identifier (LEI): 529900MVGMIVUDQY9E20
2. Reason for notification
  Acquisition/disposal of shares with voting rights
X Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:
3. Details of person subject to the notification obligation
Natural person (first name, surname): Dr. Bernard große BroermannDate of birth: 20 Nov 1943
4. Names of shareholder(s)holding directly 3% or more voting rights, if different from 3.
Asklepios Kliniken GmbH & Co. KGaA
5. Date on which threshold was crossed or reached:
28 Feb 2020
6. Total positions
  % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG
New 28.99 % 48.69 % 48.99 % 66962470
Previous notification 25.10 % n/a % 25.10 % /
7. Details on total positionsa. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG)
DE0007042301 360 19415354 0.0005 % 28.99 %
Total 19415714 28.99 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
    Total %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
right to transfer shares under share purchase agreement subject to a condition precedent 8294407 12.39 %
contribution obligation subject to a condition precedent under joint venture agreement 32601606 48.69 %
      Total 32601606 48.69 %
8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
Dr. Bernard große Broermann % % %
Asklepios Kliniken Management GmbH % % %
Asklepios Kliniken GmbH & Co. KGaA 28.69 % % 28.69 %
AMR Holding GmbH i.G. % 48.69 % 48.69 %
 
Dr. Bernard große Broermann % % %
Broermann Holding GmbH % % %
Asklepios Kliniken GmbH & Co. KGaA 28.69 % % 28.69 %
AMR Holding GmbH i.G. % 48.69 % 48.69 %
9. In case of proxy voting according to Sec. 34 para. 3 WpHG(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %
10. Other explanatory remarks:
On 28 February 2020 Asklepios Kliniken GmbH & Co. KGaA ("Asklepios") concluded a purchase agreement, subject to a condition precedent, with Eugen and Ingeborg Münch for the acquisition of a 12.39% stake in RHÖN-KLINIKUM AG ("RHÖN").Asklepios has agreed in a joint venture agreement dated 28 February 2020, subject to a condition precedent, to contribute, after closing of the purchase agreement, Asklepios' stake in RHÖN (as of 28 February 2020, taking the share purchase agreement into account: 41.07%) to AMR Holding GmbH i.G. ("AMR"). As this stake includes the 28.69% already held by Asklepios, voting rights and instruments are not aggregated in this amount. In addition, HCM SE has agreed to contribute a 7.61% stake in RHÖN to AMR subject to a condition precedent. 
Date
03 March 2020

05.03.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de